Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079066044> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- W2079066044 endingPage "7" @default.
- W2079066044 startingPage "7" @default.
- W2079066044 abstract "The Arosenius Fund was established in 1996 and is the research fund of the Swedish Haemophilia Society. The Board of the fund consists of representatives from the fields of gene therapy and haemophilia care as well as members of the Society. The fund is sponsored by unrestricted grants, and it is named after Sweden’s best loved artist Ivar Arosenius (1878–1909), who suffered from haemophilia and died at the young age of 31. He had a brother with haemophilia who died as the result of bleed at the age of 14. Ivar’s paintings reflect his disease and are a celebration of his way of life, expressing a mixture of humour and bitter sarcasm. His best-known work is the Cat Journey, which he drew for his daughter Lillian, and has become the symbol of the fund ‘Lillian and the Cat’. The aim and vision of the Arosenius Fund is to promote research for finding a cure for haemophilia. Therefore, the fund annually announces research grants currently set at 10 000 and 30 000 Euros, respectively, as well as travel grants to scientific congresses for scientists and professionals engaged in the field of haemophilia. The fund also supports symposia and lectures to reach the national and international research community. For many years an annual Arosenius lecture has been held during the WFH congress and, beginning last year, a lecture is also given at the annual meeting of the European Association of Haemophilia and Allied Disorders (EAHAD). The first lecture at the EAHAD congress was given by Professor Pier M. Mannucci. This year, Dr Carlos Rodriguez-Merchan was invited to give a lecture on haemophilic arthropathy. A review of his presentation is included in this volume. The Arosenius Fund will, during the years to come, continue its commitment to support the field of haemophilia from the perspectives of the patient, the clinic and the scientific community to contribute to the improvement of treatment and knowledge of the disease world-wide. The Arosenius Fund 2010 was sponsored by Biovitrum (main sponsor), Bayer (sponsor), Novo Nordisk (sponsor), Octapharma (sponsor), CSL Behring (sponsor) and Baxter (supporter). The authors stated that they had no interests which might be perceived as posing a conflict or bias." @default.
- W2079066044 created "2016-06-24" @default.
- W2079066044 creator A5010472135 @default.
- W2079066044 date "2011-11-02" @default.
- W2079066044 modified "2023-10-14" @default.
- W2079066044 title "The Arosenius Fund" @default.
- W2079066044 doi "https://doi.org/10.1111/j.1365-2516.2011.02688.x" @default.
- W2079066044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22044462" @default.
- W2079066044 hasPublicationYear "2011" @default.
- W2079066044 type Work @default.
- W2079066044 sameAs 2079066044 @default.
- W2079066044 citedByCount "0" @default.
- W2079066044 crossrefType "journal-article" @default.
- W2079066044 hasAuthorship W2079066044A5010472135 @default.
- W2079066044 hasBestOaLocation W20790660441 @default.
- W2079066044 hasConcept C187212893 @default.
- W2079066044 hasConcept C2778385053 @default.
- W2079066044 hasConcept C512399662 @default.
- W2079066044 hasConcept C71924100 @default.
- W2079066044 hasConceptScore W2079066044C187212893 @default.
- W2079066044 hasConceptScore W2079066044C2778385053 @default.
- W2079066044 hasConceptScore W2079066044C512399662 @default.
- W2079066044 hasConceptScore W2079066044C71924100 @default.
- W2079066044 hasIssue "1" @default.
- W2079066044 hasLocation W20790660441 @default.
- W2079066044 hasLocation W20790660442 @default.
- W2079066044 hasOpenAccess W2079066044 @default.
- W2079066044 hasPrimaryLocation W20790660441 @default.
- W2079066044 hasRelatedWork W1491311205 @default.
- W2079066044 hasRelatedWork W1586981128 @default.
- W2079066044 hasRelatedWork W2057949657 @default.
- W2079066044 hasRelatedWork W2088492288 @default.
- W2079066044 hasRelatedWork W2410491650 @default.
- W2079066044 hasRelatedWork W2604682584 @default.
- W2079066044 hasRelatedWork W2884858143 @default.
- W2079066044 hasRelatedWork W3023201287 @default.
- W2079066044 hasRelatedWork W3110692153 @default.
- W2079066044 hasRelatedWork W4235487475 @default.
- W2079066044 hasVolume "18" @default.
- W2079066044 isParatext "false" @default.
- W2079066044 isRetracted "false" @default.
- W2079066044 magId "2079066044" @default.
- W2079066044 workType "article" @default.